{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:18:23Z","timestamp":1787584703706,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01 OD031809"],"award-info":[{"award-number":["K01 OD031809"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"DOI":"10.1186\/s12917-025-05030-1","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T03:24:16Z","timestamp":1760066656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lattice radiation therapy for canine sinonasal carcinoma: feasibility study of spatially fractionated radiotherapy using volumetric modulated arc therapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Patricia","family":"Gualtieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Prebble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Keara","family":"Boss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Del","family":"Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"1","key":"5030_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijrobp.2019.01.073","volume":"104","author":"C Billena","year":"2019","unstructured":"Billena C, Khan AJ. A current review of spatial fractionation: back to the future?? Int J Radiat Oncol Biol Phys. 2019;104(1):177\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"5030_CR2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ijrobp.2020.03.028","volume":"107","author":"RJ Griffin","year":"2020","unstructured":"Griffin RJ, Ahmed MM, Amendola B, Belyakov O, Bentzen SM, Butterworth KT, et al. Understanding high-dose, ultra-high dose rate, and spatially fractionated radiation therapy. Int J Radiat Oncol Biol Phys. 2020;107(4):766\u201378.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"5030_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2020.100639","volume":"6","author":"S Duriseti","year":"2021","unstructured":"Duriseti S, Kavanaugh J, Goddu S, Price A, Knutson N, Reynoso F, et al. Spatially fractionated stereotactic body radiation therapy (lattice) for large tumors. Adv Radiat Oncol. 2021;6(3):100639.","journal-title":"Adv Radiat Oncol"},{"key":"5030_CR4","first-page":"100569","volume":"39","author":"F Iori","year":"2023","unstructured":"Iori F, Cappelli A, D\u2019Angelo E, Cozzi S, Ghersi SF, De Felice F, et al. Lattice radiation therapy in clinical practice: A systematic review. Clin Transl Radiat Oncol. 2023;39:100569.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"5030_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.semradonc.2024.05.002","volume":"34","author":"MM Ahmed","year":"2024","unstructured":"Ahmed MM, Wu X, Mohiuddin M, Perez NC, Zhang H, Amendola BE, et al. Optimizing GRID and lattice spatially fractionated radiation therapy: innovative strategies for radioresistant and bulky tumor management. Semin Radiat Oncol. 2024;34(3):310\u201322.","journal-title":"Semin Radiat Oncol"},{"issue":"6","key":"5030_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1667\/RR2780.1","volume":"177","author":"RS Asur","year":"2012","unstructured":"Asur RS, Sharma S, Chang CW, Penagaricano J, Kommuru IM, Moros EG, et al. Spatially fractionated radiation induces cytotoxicity and changes in gene expression in bystander and radiation adjacent murine carcinoma cells. Radiat Res. 2012;177(6):751\u201365.","journal-title":"Radiat Res"},{"issue":"1","key":"5030_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2013.10.032","volume":"356","author":"R Asur","year":"2015","unstructured":"Asur R, Butterworth KT, Penagaricano JA, Prise KM, Griffin RJ. High dose bystander effects in spatially fractionated radiation therapy. Cancer Lett. 2015;356(1):52\u20137.","journal-title":"Cancer Lett"},{"issue":"2","key":"5030_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/153303460200100207","volume":"1","author":"S Sathishkumar","year":"2002","unstructured":"Sathishkumar S, Dey S, Meigooni AS, Regine WF, Kudrimoti MS, Ahmed MM, et al. The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation. Technol Cancer Res Treat. 2002;1(2):141\u20137.","journal-title":"Technol Cancer Res Treat"},{"issue":"2","key":"5030_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1667\/RR3819.1","volume":"182","author":"S Kanagavelu","year":"2014","unstructured":"Kanagavelu S, Gupta S, Wu X, Philip S, Wattenberg MM, Hodge JW, et al. In vivo effects of lattice radiation therapy on local and distant lung cancer: potential role of immunomodulation. Radiat Res. 2014;182(2):149\u201362.","journal-title":"Radiat Res"},{"issue":"1","key":"5030_CR10","doi-asserted-by":"publisher","first-page":"8845","DOI":"10.1038\/s41467-024-53015-9","volume":"15","author":"P Bergeron","year":"2024","unstructured":"Bergeron P, Dos Santos M, Sitterle L, Tarlet G, Lavigne J, Liu W, et al. Non-homogenous intratumor ionizing radiation doses synergize with PD1 and CXCR2 blockade. Nat Commun. 2024;15(1):8845.","journal-title":"Nat Commun"},{"key":"5030_CR11","doi-asserted-by":"publisher","first-page":"548132","DOI":"10.3389\/fonc.2020.548132","volume":"10","author":"L Jiang","year":"2020","unstructured":"Jiang L, Li X, Zhang J, Li W, Dong F, Chen C, et al. Combined High-Dose LATTICE radiation therapy and immune checkpoint Blockade for advanced bulky tumors: the concept and a case report. Front Oncol. 2020;10:548132.","journal-title":"Front Oncol"},{"key":"5030_CR12","volume":"40","author":"S Tubin","year":"2023","unstructured":"Tubin S, Vozenin MC, Prezado Y, Durante M, Prise KM, Lara PC, et al. Novel unconventional radiotherapy techniques: current status and future perspectives - Report from the 2nd international radiation oncology online seminar. Clin Transl Radiat Oncol. 2023;40:100605.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"5030_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.zemedi.2011.07.002","volume":"22","author":"JA Laissue","year":"2012","unstructured":"Laissue JA, Blattmann H, Slatkin DN. [Alban Kohler (1874\u20131947): inventor of grid therapy]. Z Med Phys. 2012;22(2):90\u20139.","journal-title":"Z Med Phys"},{"issue":"1","key":"5030_CR14","first-page":"46","volume":"17","author":"H Marks","year":"1950","unstructured":"Marks H. A new approach to the Roentgen therapy of cancer with the use of a grid. J Mt Sinai Hosp N Y. 1950;17(1):46\u20138.","journal-title":"J Mt Sinai Hosp N Y"},{"issue":"3","key":"5030_CR15","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1148\/58.3.338","volume":"58","author":"H Marks","year":"1952","unstructured":"Marks H. Clinical experience with irradiation through a grid. Radiology. 1952;58(3):338\u201342.","journal-title":"Radiology"},{"issue":"3","key":"5030_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0360-3016(99)00170-4","volume":"45","author":"M Mohiuddin","year":"1999","unstructured":"Mohiuddin M, Fujita M, Regine WF, Megooni AS, Ibbott GS, Ahmed MM. High-dose spatially-fractionated radiation (GRID): a new paradigm in the management of advanced cancers. Int J Radiat Oncol Biol Phys. 1999;45(3):721\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5030_CR17","doi-asserted-by":"crossref","unstructured":"Wu XA, Ahmed MM, Wright J, et al. (March 05, 2010) On Modern Technical Approaches of Three-Dimensional High-Dose Lattice Radiotherapy (LRT). Cureus 2(3): e9. doi:10.7759\/cureus.9","DOI":"10.7759\/cureus.9"},{"issue":"12","key":"5030_CR18","doi-asserted-by":"publisher","first-page":"7359","DOI":"10.1002\/mp.16572","volume":"50","author":"W Zhang","year":"2023","unstructured":"Zhang W, Lin Y, Wang F, Badkul R, Chen RC, Gao H. Lattice position optimization for LATTICE therapy. Med Phys. 2023;50(12):7359\u201367.","journal-title":"Med Phys"},{"issue":"5","key":"5030_CR19","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.ijrobp.2011.01.065","volume":"82","author":"G Neuner","year":"2012","unstructured":"Neuner G, Mohiuddin MM, Vander Walde N, Goloubeva O, Ha J, Yu CX, et al. High-dose spatially fractionated GRID radiation therapy (SFGRT): a comparison of treatment outcomes with Cerrobend vs. MLC SFGRT. Int J Radiat Oncol Biol Phys. 2012;82(5):1642\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"5030_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2023.101308","volume":"9","author":"NA Mayr","year":"2024","unstructured":"Mayr NA, Mohiuddin M, Snider JW, Zhang H, Griffin RJ, Amendola BE, et al. Practice patterns of spatially fractionated radiation therapy: a clinical practice survey. Adv Radiat Oncol. 2024;9(2):101308.","journal-title":"Adv Radiat Oncol"},{"key":"5030_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2021.12.003","volume":"167","author":"JA Kavanaugh","year":"2022","unstructured":"Kavanaugh JA, Spraker MB, Duriseti S, Basarabescu F, Price A, Goddu M, et al. Lite SABR M1: planning design and dosimetric endpoints for a phase I trial of lattice SBRT. Radiother Oncol. 2022;167:172\u20138.","journal-title":"Radiother Oncol"},{"key":"5030_CR22","first-page":"68","volume":"9","author":"BE Amendola","year":"2018","unstructured":"Amendola BE, Perez NC, Wu X, Blanco Suarez JM, Lu JJ, Amendola M. Improved outcome of treating locally advanced lung cancer with the use of lattice radiotherapy (LRT): a case report. Clin Transl Radiat Oncol. 2018;9:68\u201371.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"5030_CR23","first-page":"e4263","volume":"11","author":"BE Amendola","year":"2019","unstructured":"Amendola BE, Perez NC, Wu X, Amendola MA, Qureshi IZ. Safety and efficacy of lattice radiotherapy in voluminous non-small cell lung cancer. Cureus. 2019;11(3):e4263.","journal-title":"Cureus"},{"key":"5030_CR24","doi-asserted-by":"publisher","unstructured":"Amendola BP, Perez N, et al. Lattice Radiotherapy with RapidArc for Treatment of Gynecological Tumors: Dosimetric and Early Clinical Evaluations. Cureus 2010;2(9):e15. https:\/\/doi.org\/10.7759\/cureus.15.","DOI":"10.7759\/cureus.15"},{"key":"5030_CR25","volume":"48","author":"P Xu","year":"2024","unstructured":"Xu P, Wang S, Zhou J, Yuan K, Wang X, Li L, et al. Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer. Clin Transl Radiat Oncol. 2024;48:100830.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"12","key":"5030_CR26","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.21037\/apm-22-1119","volume":"11","author":"F Wang","year":"2022","unstructured":"Wang F, Ong ALK. Lattice radiotherapy: where less is more? Ann Palliat Med. 2022;11(12):3587\u201391.","journal-title":"Ann Palliat Med"},{"issue":"2","key":"5030_CR27","first-page":"161","volume":"199","author":"F Ertan","year":"2023","unstructured":"Ertan F, Yeginer M, Zorlu F. Dosimetric performance evaluation of MLC-based and Cone-based 3D spatially fractionated LATTICE radiotherapy. Radiat Res. 2023;199(2):161\u20139.","journal-title":"Radiat Res"},{"issue":"6","key":"5030_CR28","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1667\/RADE-20-00065.1","volume":"194","author":"AJ Johnsrud","year":"2020","unstructured":"Johnsrud AJ, Jenkins SV, Jamshidi-Parsian A, Quick CM, Galhardo EP, Dings RPM, et al. Evidence for early stage anti-tumor immunity elicited by spatially fractionated radiotherapy-immunotherapy combinations. Radiat Res. 2020;194(6):688\u201397.","journal-title":"Radiat Res"},{"issue":"765","key":"5030_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adk0642","volume":"16","author":"JC Jagodinsky","year":"2024","unstructured":"Jagodinsky JC, Vera JM, Jin WJ, Shea AG, Clark PA, Sriramaneni RN, et al. Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade. Sci Transl Med. 2024;16(765):eadk0642.","journal-title":"Sci Transl Med"},{"issue":"12","key":"5030_CR30","first-page":"e417","volume":"7","author":"M Mohiuddin","year":"2015","unstructured":"Mohiuddin M, Park H, Hallmeyer S, Richards J. High-dose radiation as a dramatic, immunological primer in locally advanced melanoma. Cureus. 2015;7(12):e417.","journal-title":"Cureus"},{"key":"5030_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.radonc.2021.06.037","volume":"162","author":"RR Patel","year":"2021","unstructured":"Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, et al. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: results of a phase II trial. Radiother Oncol. 2021;162:60\u20137.","journal-title":"Radiother Oncol"},{"issue":"3","key":"5030_CR32","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/1533034617690980","volume":"16","author":"MW Nolan","year":"2017","unstructured":"Nolan MW, Gieger TL, Karakashian AA, Nikolova-Karakashian MN, Posner LP, Roback DM, et al. Outcomes of spatially fractionated radiotherapy (GRID) for bulky soft tissue sarcomas in a large animal model. Technol Cancer Res Treat. 2017;16(3):357\u201365.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"5030_CR33","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","volume":"13","author":"LB Darragh","year":"2022","unstructured":"Darragh LB, Gadwa J, Pham TT, Van Court B, Neupert B, Olimpo NA, et al. Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors. Nat Commun. 2022;13(1):7015.","journal-title":"Nat Commun"},{"key":"5030_CR34","doi-asserted-by":"crossref","unstructured":"Boss MK, Watts R, Harrison LG, Hopkins S, Chow L, Trageser E, et al. Immunologic effects of stereotactic body radiotherapy in dogs with spontaneous tumors and the impact of intratumoral OX40\/TLR agonist immunotherapy. Int J Mol Sci. 2022.","DOI":"10.3390\/ijms23020826"},{"issue":"6","key":"5030_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1667\/RADE-24-00079.1","volume":"202","author":"P Gualtieri","year":"2024","unstructured":"Gualtieri P, Lee BI, Beeney A, Hart C, Leary D, Martin T, et al. Response of spontaneous oral tumors in canine cancer patients treated with stereotactic body radiation therapy (SBRT). Radiat Res. 2024;202(6):807\u201324.","journal-title":"Radiat Res"},{"key":"5030_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1202265","volume":"10","author":"P Gualtieri","year":"2023","unstructured":"Gualtieri P, Martin T, Leary D, Lana SE, LaRue SM, Boss MK. Canine salivary gland carcinoma treated with stereotactic body radiation therapy: a retrospective case series. Front Vet Sci. 2023;10:1202265.","journal-title":"Front Vet Sci"},{"issue":"4","key":"5030_CR37","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/vco.12625","volume":"18","author":"BI Lee","year":"2020","unstructured":"Lee BI, LaRue SM, Seguin B, Griffin L, Prebble A, Martin T, et al. Safety and efficacy of stereotactic body radiation therapy (SBRT) for the treatment of canine thyroid carcinoma. Vet Comp Oncol. 2020;18(4):843\u201353.","journal-title":"Vet Comp Oncol"},{"issue":"1","key":"5030_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/vru.13039","volume":"63","author":"BI Lee","year":"2022","unstructured":"Lee BI, Boss MK, LaRue SM, Martin T, Leary D. Comparative study of the collapsed cone convolution and Monte Carlo algorithms for radiation therapy planning of canine sinonasal tumors reveals significant dosimetric differences. Vet Radiol Ultrasound. 2022;63(1):91\u2013101.","journal-title":"Vet Radiol Ultrasound"},{"issue":"3","key":"5030_CR39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2460\/javma.229.3.401","volume":"229","author":"KM Rassnick","year":"2006","unstructured":"Rassnick KM, Goldkamp CE, Erb HN, Scrivani PV, Njaa BL, Gieger TL, et al. Evaluation of factors associated with survival in dogs with untreated nasal carcinomas: 139 cases (1993\u20132003). J Am Vet Med Assoc. 2006;229(3):401\u20136.","journal-title":"J Am Vet Med Assoc"},{"issue":"1","key":"5030_CR40","doi-asserted-by":"publisher","first-page":"E68","DOI":"10.1111\/vco.12334","volume":"16","author":"TL Gieger","year":"2018","unstructured":"Gieger TL, Nolan MW. Linac-based stereotactic radiation therapy for canine non-lymphomatous nasal tumours: 29 cases (2013\u20132016). Vet Comp Oncol. 2018;16(1):E68\u201375.","journal-title":"Vet Comp Oncol"},{"issue":"12","key":"5030_CR41","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2460\/javma.22.03.0141","volume":"260","author":"MW Nolan","year":"2022","unstructured":"Nolan MW, Berman AR, Watson-Skaggs ML, Quinn CN, Marcus KL, Russell K, et al. Stereotactic radiotherapy (10 Gy X 3) for canine nonlymphomatous intranasal tumors is associated with prolonged survival and minimal risk of severe radiotoxicity. J Am Vet Med Assoc. 2022;260(12):1496\u2013506.","journal-title":"J Am Vet Med Assoc"},{"issue":"6","key":"5030_CR42","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1111\/jvim.16838","volume":"37","author":"H Yoshikawa","year":"2023","unstructured":"Yoshikawa H, Lafferty MH, Griffin LR, LaRue SM. A retrospective study of sinonasal tumors in 182 dogs treated with stereotactic radiotherapy (3 x 10 Gy) (2010\u20132015). J Vet Intern Med. 2023;37(6):2356\u201367.","journal-title":"J Vet Intern Med"},{"issue":"2","key":"5030_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/j.1740-8261.2009.01522.x","volume":"50","author":"J Harmon","year":"2009","unstructured":"Harmon J, Van Ufflen D, Larue S. Assessment of a radiotherapy patient cranial immobilization device using daily on-board kilovoltage imaging. Vet Radiol Ultrasound. 2009;50(2):230\u20134.","journal-title":"Vet Radiol Ultrasound"},{"issue":"3","key":"5030_CR44","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semradonc.2024.04.004","volume":"34","author":"ME Takashima","year":"2024","unstructured":"Takashima ME, Berg TJ, Morris ZS. The effects of radiation dose heterogeneity on the tumor microenvironment and anti-tumor immunity. Semin Radiat Oncol. 2024;34(3):262\u201371.","journal-title":"Semin Radiat Oncol"},{"key":"5030_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmp.2024.104490","volume":"125","author":"M Gaudreault","year":"2024","unstructured":"Gaudreault M, Yu KK, Chang D, Kron T, Hardcastle N, Chander S, et al. Automated lattice radiation therapy treatment planning personalised to tumour size and shape. Phys Med. 2024;125:104490.","journal-title":"Phys Med"},{"issue":"5","key":"5030_CR46","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1118\/1.3582690","volume":"38","author":"T Han","year":"2011","unstructured":"Han T, Mikell JK, Salehpour M, Mourtada F. Dosimetric comparison of acuros XB deterministic radiation transport method with Monte Carlo and model-based convolution methods in heterogeneous media. Med Phys. 2011;38(5):2651\u201364.","journal-title":"Med Phys"},{"key":"5030_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1748-717X-8-149","volume":"8","author":"PS Kroon","year":"2013","unstructured":"Kroon PS, Hol S, Essers M. Dosimetric accuracy and clinical quality of acuros XB and AAA dose calculation algorithm for stereotactic and conventional lung volumetric modulated arc therapy plans. Radiat Oncol. 2013;8:149.","journal-title":"Radiat Oncol"},{"issue":"5","key":"5030_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1120\/jacmp.v16i5.5589","volume":"16","author":"EA Alhakeem","year":"2015","unstructured":"Alhakeem EA, AlShaikh S, Rosenfeld AB, Zavgorodni SF. Comparative evaluation of modern dosimetry techniques near low- and high-density heterogeneities. J Appl Clin Med Phys. 2015;16(5):142\u201358.","journal-title":"J Appl Clin Med Phys"},{"key":"5030_CR49","doi-asserted-by":"publisher","unstructured":"Hoffmann L, Alber M, S\u00f6hn M, Elstr\u00f8m UV. Validation of the Acuros XB dose calculation algorithm versus Monte Carlo for clinical treatment plans. Med Phys. 2018. https:\/\/doi.org\/10.1002\/mp.13053.","DOI":"10.1002\/mp.13053"},{"key":"5030_CR50","unstructured":"Sievinen J, Ulmer W, Kaissl W. AAA photon dose calculation model in Eclipse. Varian Documentation. Palo Alto, CA: Varian Medical Systems. 2005."},{"issue":"3","key":"5030_CR51","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.meddos.2022.04.007","volume":"47","author":"Z Gopalakrishnan","year":"2022","unstructured":"Gopalakrishnan Z, Bhasi S, Menon PR, Thayil SVBS. Dosimetric comparison of analytical anisotropic algorithm and the two dose reporting modes of acuros XB dose calculation algorithm in volumetric modulated Arc therapy of carcinoma lung and carcinoma prostate. Med Dosim. 2022;47(3):280\u20137.","journal-title":"Med Dosim"},{"key":"5030_CR52","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13014-014-0286-3","volume":"9","author":"S Padmanaban","year":"2014","unstructured":"Padmanaban S, Warren S, Walsh A, Partridge M, Hawkins MA. Comparison of acuros (AXB) and anisotropic analytical algorithm (AAA) for dose calculation in treatment of oesophageal cancer: effects on modelling tumour control probability. Radiat Oncol. 2014;9:286.","journal-title":"Radiat Oncol"},{"issue":"11","key":"5030_CR53","doi-asserted-by":"publisher","first-page":"e0207232","DOI":"10.1371\/journal.pone.0207232","volume":"13","author":"KH Kim","year":"2018","unstructured":"Kim KH, Chung JB, Suh TS, Kang SW, Kang SH, Eom KY, et al. Dosimetric and radiobiological comparison in different dose calculation grid sizes between acuros XB and anisotropic analytical algorithm for prostate VMAT. PLoS One. 2018;13(11):e0207232.","journal-title":"PLoS One"},{"issue":"2","key":"5030_CR54","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1118\/1.1843354","volume":"32","author":"JF Dempsey","year":"2005","unstructured":"Dempsey JF, Romeijn HE, Li JG, Low DA, Palta JR. A fourier analysis of the dose grid resolution required for accurate IMRT fluence map optimization. Med Phys. 2005;32(2):380\u20138.","journal-title":"Med Phys"},{"issue":"19","key":"5030_CR55","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1088\/0031-9155\/51\/19\/008","volume":"51","author":"H Chung","year":"2006","unstructured":"Chung H, Jin H, Palta J, Suh TS, Kim S. Dose variations with varying calculation grid size in head and neck IMRT. Phys Med Biol. 2006;51(19):4841\u201356.","journal-title":"Phys Med Biol"},{"issue":"4","key":"5030_CR56","first-page":"303","volume":"4","author":"C Snyder Karen","year":"2017","unstructured":"Snyder Karen C, Liu M, Zhao B, Huang Y, Ning W, Chetty IJ, et al. Investigating the dosimetric effects of grid size on dose calculation accuracy using volumetric modulated Arc therapy in spine stereotactic radiosurgery. J Radiosurg SBRT. 2017;4(4):303\u201313.","journal-title":"J Radiosurg SBRT"},{"key":"5030_CR57","doi-asserted-by":"crossref","unstructured":"Hodapp N, [The ICRU. Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT)]. Strahlenther Onkol. 2012;188(1):97\u20139.","DOI":"10.1007\/s00066-011-0015-x"},{"key":"5030_CR58","doi-asserted-by":"crossref","unstructured":"Prezado Y, Grams M, Jouglar E, Martinez-Rovira I, Ortiz R, Seco J, et al. Spatially fractionated radiation therapy: a critical review on current status of clinical and preclinical studies and knowledge gaps. Phys Med Biol. 2024.","DOI":"10.1088\/1361-6560\/ad4192"},{"issue":"4","key":"5030_CR59","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.ijrobp.2022.03.030","volume":"113","author":"T Friedrich","year":"2022","unstructured":"Friedrich T, Scholz M, Durante M. A predictive biophysical model of the combined action of radiation therapy and immunotherapy of cancer. Int J Radiat Oncol Biol Phys. 2022;113(4):872\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"5030_CR60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ijrobp.2018.10.009","volume":"103","author":"E Markovsky","year":"2019","unstructured":"Markovsky E, Budhu S, Samstein RM, Li H, Russell J, Zhang Z, et al. An antitumor immune response is evoked by partial-volume single-dose radiation in 2 murine models. Int J Radiat Oncol Biol Phys. 2019;103(3):697\u2013708.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"5030_CR61","doi-asserted-by":"publisher","first-page":"e0229053","DOI":"10.1371\/journal.pone.0229053","volume":"15","author":"JN Rivera","year":"2020","unstructured":"Rivera JN, Kierski TM, Kasoji SK, Abrantes AS, Dayton PA, Chang SX. Conventional dose rate spatially-fractionated radiation therapy (SFRT) treatment response and its association with dosimetric parameters-a preclinical study in a Fischer 344 rat model. PLoS ONE. 2020;15(6):e0229053.","journal-title":"PLoS ONE"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-05030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-025-05030-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-025-05030-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:02:57Z","timestamp":1760072577000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-025-05030-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5030"],"URL":"https:\/\/doi.org\/10.1186\/s12917-025-05030-1","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This was an in-silico study; no radiotherapy plans were delivered to patients. Client consent was previously obtained for general anesthesia and advanced imaging acquisition as part of an ongoing clinical trial for canine sinonasal carcinoma (Colorado State University Institutional Animal Care and Use Committee [IACUC] Protocol #6179; clinical trial number: not applicable). As a research and teaching institution, Colorado State University is obligated to meet federal standards regarding their animal care policies and practices. These include oversight from the United States (US) Department of Health and Human Services (HHS) and the US Department of Agriculture (USDA). All personnel using animals for research, testing or teaching are required to comply with applicable US federal regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"598"}}